Clinical Trial Update: Terlipressin Given As I.V. Boluses Versus Terlipressin Given As Continuous Intravenous Infusion In Patients With Cirrhosis And Type 1 Hepatorenal Syndrome [Phase 2, Phase 3]

View source ↗

Summary

The document reports a Phase 2/3 clinical trial comparing intravenous bolus administration of terlipressin to continuous intravenous infusion in patients with c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Hepatorenal Syndrome

Drugs mentioned

• Terlipressin (terlipressin)

Snippet

Sponsor: University of Padova | Conditions: Cirrhosis, Type 1 Hepatorenal Syndrome | Phase 2, Phase 3 | Status: UNKNOWN